Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma

NCT00443976 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

NETWORK

Sponsor class

Conditions

Non-Hodgkins Lymphoma
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: Aurora kinase inhibitor AT9283

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]